New options for late-line treatment of metastatic colorectal cancer
Nat Rev Gastroenterol Hepatol
.
2024 Feb;21(2):76-77.
doi: 10.1038/s41575-023-00881-1.
Authors
Sara Lonardi
1
,
Filippo Pietrantonio
2
Affiliations
1
Oncology Department, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. sara.lonardi@iov.veneto.it.
2
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
PMID:
38066100
DOI:
10.1038/s41575-023-00881-1
No abstract available
MeSH terms
Antibodies, Monoclonal / therapeutic use
Antineoplastic Combined Chemotherapy Protocols
Colorectal Neoplasms* / therapy
Humans
Intestine, Large
Rectal Neoplasms*
Substances
Antibodies, Monoclonal